Morphic Holding Inc at RBC Capital Markets Global Healthcare Conference Transcript
Okay. Welcome back, everyone, to the 2023 RBC Global Healthcare Conference. And my name is Greg Renza, one of the biotechnology equity research analysts here. And we're pleased to be joined by Morphic, Morphic Therapeutic. Representing the company is the Chief Operating Officer, Chief Financial Officer, Mark Schegerin.
Marc, it's great to see you.
Thanks for having me.
And look forward to hearing more about the recent data, the progress with the 057, and certainly the MInT Platform. A lot has happened in the last several weeks, the last quarter. But you've got a very interesting portfolio to really join the lead asset, 057.
Questions & Answers
Maybe just have you give a brief intro to the company, to the portfolio, and what more is working on?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
